Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification
Status:
Completed
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
The following trial hypothesis will be proved: In patients with atrial fibrillation and/ or
pulmonary embolism standard anticoagulant treatment with coumadin/phenprocoumon is associated
with accelerated coronary or valvular calcification as assessed by cardiac computed
tomography compared to the new anticoagulant therapy with rivaroxaban.